Home
Conditions
Estrogen Receptor-positive Breast Cancer

Clinical trial condition

Estrogen Receptor-positive Breast Cancer

Explore clinical trials studying Estrogen Receptor-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

30 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Estrogen Receptor-positive Breast Cancer trial results

Completed

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

NCT03633331

Conditions: Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 447 locations

View Trial Details

Completed

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

NCT02186470

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Pre-operative Immunotherapy Combination Strategies in Breast Cancer

NCT03395899

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Barts Health NHS Trust London, United Kingdom

View Trial Details

Completed

Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

NCT03719495

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Patterns of Prescribing and Monitoring of Palbociclib

NCT03285568

Conditions: Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Not specified

View Trial Details

Completed

Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors

NCT02235051

Conditions: Breast Diseases, Breast Neoplasms, Cancer Survivor, +11 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

NCT00676663

Conditions: Animal Diseases, Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, +9 more
Locations: California Cancer Care Greenbrae, California, United States

Moores UCSD Cancer Center La Jolla, California, United States

Scripps Health La Jolla, California, United States

University of Colorado Aurora, Colorado, United States

View all 38 locations

View Trial Details

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

NCT02015559

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +11 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

NCT00602043

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +8 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Estrogen Receptor-positive Breast Cancer

Estrogen Receptor-positive Breast Cancer trial results

Related conditions